References
- Chen M G, Mott K E. Progress in assessment of morbidity due to Schistosoma mansoni infection. Trop Dis Bull 1988; 85: R1–R56
- Lyra L G, Reboucas G, Andrade Z A. Hepatitis B surface antigen carrier state in hepatosplenic schistosomiasis. Gastroenterology 1976; 71: 641–645
- Levrero M, Tagger A, Balsano C, et al. Antibodies to hepatitis C virus in patients with hepatocellular carcinoma. J Hepatol 1991; 12: 60–63
- Bruix J, Barrera J M, Calvet X, et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989; 2: 1004–1006
- Esteban J I, Lopez-Talavera J C, Genesca J, et al. High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus. Ann Intern Med 1991; 115: 443–449
- Hyams K C, Mansour M M, Massoud A, Dunn M A. Parenteral therapy: A potential risk factor for hepatitis B infection. J Med Virol 1987; 23: 109–114